As later described in section Review of 1 H MRS Studies Evaluating Glutamate or Glx, GABA, and Glutathione in ALS, the majority of MRS studies performed to date in ALS patients are at 1.5 and 3.0 T, which frequently report the combined signal of glutamate and glutamine, defined as Glx
This makes it a promising candidate for: Neurological recovery Cognitive function improvement Mental clarity Joint and Muscle Recovery Anecdotally and in clinical trials, BPC-157 has been reported to aid in the recovery of strained muscles and damaged joints, accelerating both recovery and healing
Canavese M, Altruda F, Ruzicka T, and Schauber J (2010 Barkmeier A
10 , eaaf7444 (2018)
This is an essential insight for those attending, but if you cant make the day, please enjoy the free gift anyway